Benin Prostatic Hyperplasis Devices Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Benin Prostatic Hyperplasis Devices Market to 2027 - Global Analysis and Forecasts By Procedure Type (Transurethral Microwave Therapy, Transurethral Resection of the Prostate, Transurethral Needle Ablation of the Prostate, Prostatic Stenting, Laser Surgery and Others), End User (Hospitals & Clinics, Ambulatory Surgical Centers and Others) and Geography

Report Code: TIPMD00002609 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
The enlargement of the prostate gland is known as benign prostatic hyperplasia (BPH). The enlargement of this gland is generally seen in the baby boomers. This may cause symptom such as uncomfortable urine and can also cause bladder or kidney problems. The risk factors for the enlarged prostate glands are aging, family history, diabetes, heart disease and lifestyle.

The benign prostatic hyperplasia devices market is anticipated to grow with a significant rate in the forecast years, owing to driving factors such as, increase in the geriatric population, increase in the awareness for prostate cancer and other urological disorders. The market is likely to open up the road ahead for the development of the innovative products that are minimally invasive and the also have opportunities to enter the developing nations across the world.

The "Global Benign Prostatic Hyperplasia Devices Market Analysis To 2027" is a specialized and in-depth study of the medical device industry with a focus on the benign prostatic hyperplasia devices market trend. The report aims to provide an overview of global benign prostatic hyperplasia devices market with detailed market segmentation by procedure type, end user and geography. The global benign prostatic hyperplasia devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the Benign Prostatic Hyperplasia devices market.

The global benign prostatic hyperplasia devices market is segmented on the basis of procedure type and end user. On the basis of the procedure type the segment is classified as transurethral microwave therapy, transurethral resection of the prostate, transurethral needle ablation of the prostate, prostatic stenting, laser surgery and others. On the basis of the end user the market is segmented as hospitals & clinics, ambulatory surgical centers and others.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global benign prostatic hyperplasia devices market based on product, material, end user and geography. It also provides market size and forecast till 2027 for overall benign prostatic hyperplasia devices market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the benign prostatic hyperplasia devices market owing to the rising prevalence of benign prostatic hyperplasia. Europe is anticipated to share second position of the market in the forecasted period. Also, Asia is expected to be the fastest growing market due to the rise in various urological disorders and complications.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key benign prostatic hyperplasia devices market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Karl Storz Gmbh & Co.Kg, Olympus, Lumenis, Boston Scientific Corporation, NeoTract, Inc., Coloplast Pty Ltd, Dornier MedTech., Richard Wolf GmbH, NxThera, Inc. and Convergent Laser Technologies

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Benign Prostatic Hyperplasia Devices Market - By Procedure Type
3.2.2. Benign Prostatic Hyperplasia Devices Market - By End User
3.2.3. Benign Prostatic Hyperplasia Devices Market - By Region
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis

4. BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET - GLOBAL ANALYSIS
5.1. GLOBAL BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET OVERVIEW
5.2. GLOBAL BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS

6. BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS TO 2027 - BY PROCEDURE TYPE
6.1. OVERVIEW
6.2. PROCEDURE TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. TRANSURETHRAL MICROWAVE THERAPY MARKET
6.3.1. Overview
6.3.2. Transurethral Microwave Therapy Market Revenue Forecasts and Analysis (US$ Mn)
6.4. TRANSURETHRAL RESECTION OF THE PROSTATE MARKET
6.4.1. Overview
6.4.2. Transurethral Resection of the Prostate Market Revenue Forecasts and Analysis (US$ Mn)
6.5. TRANSURETHRAL NEEDLE ABLATION OF THE PROSTATE MARKET
6.5.1. Overview
6.5.2. Transurethral Needle Ablation of the Prostate Market Revenue Forecasts and Analysis (US$ Mn)
6.6. PROSTATIC STENTING MARKET
6.6.1. Overview
6.6.2. Prostatic Stenting Market Revenue Forecasts and Analysis (US$ Mn)
6.7. LASER SURGERY MARKET
6.7.1. Overview
6.7.2. Laser Surgery Market Revenue Forecasts and Analysis (US$ Mn)
6.8. OTHERS MARKET
6.8.1. Overview
6.8.2. Others Market Revenue Forecasts and Analysis (US$ Mn)


7. BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
7.1. OVERVIEW
7.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. HOSPITALS & CLINICS MARKET
7.3.1. Overview
7.3.2. Hospitals & Clinics Market Revenue Forecasts and Analysis (US$ Mn)
7.4. AMBULATORY SURGICAL CENTERS MARKET
7.4.1. Overview
7.4.2. Ambulatory Surgical Centers Market Revenue Forecasts and Analysis (US$ Mn)
7.5. OTHERS MARKET
7.5.1. Overview
7.5.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

8. NORTH AMERICA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
8.1. NORTH AMERICA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET OVERVIEW
8.2. NORTH AMERICA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. NORTH AMERICA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY PROCEDURE TYPE (US$ MN)
8.4. NORTH AMERICA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
8.5. NORTH AMERICA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
8.6. US MARKET OVERVIEW
8.6.1. US Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
8.6.2. US Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8.7. CANADA MARKET OVERVIEW
8.7.1. Canada Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
8.7.2. Canada Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8.8. MEXICO MARKET OVERVIEW
8.8.1. Mexico Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
8.8.2. Mexico Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)

9. EUROPE BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. EUROPE BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET OVERVIEW
9.2. EUROPE BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. EUROPE BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY PROCEDURE TYPE (US$ MN)
9.4. EUROPE BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.5. EUROPE BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.6. UK MARKET OVERVIEW
9.6.1. UK Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
9.6.2. UK Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.7. GERMANY MARKET OVERVIEW
9.7.1. Germany Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
9.7.2. Germany Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. FRANCE MARKET OVERVIEW
9.8.1. France Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
9.8.2. France Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)

10. ASIA PACIFIC BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. ASIA PACIFIC BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET OVERVIEW
10.2. ASIA PACIFIC BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. ASIA PACIFIC BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY PROCEDURE TYPE (US$ MN)
10.4. ASIA PACIFIC BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.5. ASIA PACIFIC BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.6. CHINA MARKET OVERVIEW
10.6.1. China Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
10.6.2. China Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.7. JAPAN MARKET OVERVIEW
10.7.1. Japan Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
10.7.2. Japan Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. INDIA MARKET OVERVIEW
10.8.1. India Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
10.8.2. India Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)

11. MIDDLE EAST AND AFRICA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. MIDDLE EAST AND AFRICA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET OVERVIEW
11.2. MIDDLE EAST AND AFRICA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. MIDDLE EAST AND AFRICA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY PROCEDURE TYPE (US$ MN)
11.4. MIDDLE EAST AND AFRICA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.5. MIDDLE EAST AND AFRICA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.6. UAE MARKET OVERVIEW
11.6.1. UAE Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
11.6.2. UAE Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.7. SAUDI ARABIA MARKET OVERVIEW
11.7.1. Saudi Arabia Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
11.7.2. Saudi Arabia Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. SOUTH AFRICA MARKET OVERVIEW
11.8.1. South Africa Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
11.8.2. South Africa Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)

12. SOUTH AND CENTRAL AMERICA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. SOUTH AND CENTRAL AMERICA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET OVERVIEW
12.2. SOUTH AND CENTRAL AMERICA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. SOUTH AND CENTRAL AMERICA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY PROCEDURE TYPE (US$ MN)
12.4. SOUTH AND CENTRAL AMERICA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.5. SOUTH AND CENTRAL AMERICA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.6. BRAZIL MARKET OVERVIEW
12.6.1. Brazil Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
12.6.2. Brazil Benign Prostatic Hyperplasia Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)

13. INDUSTRY LANDSCAPE
13.1. 1.1.ORGANIC GROWTH STRATEGIES
13.1.1. New Product Launches
13.1.2. Marketing & Promotional Activities
13.2. 1.2.INORGANIC GROWTH STRATEGIES
13.2.1. Partnerships, Collaborations, and Joint Ventures
13.2.2. Mergers & Acquisitions

14. BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, KEY COMPANY PROFILES
14.1. KARL STORZ GMBH & CO.KG
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. OLYMPUS
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. LUMENIS
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Financial Overview
14.3.4. Type/Type Portfolio
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. BOSTON SCIENTIFIC CORPORATION
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. NEOTRACT, INC.
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. COLOPLAST PTY LTD
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. DORNIER MEDTECH.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. RICHARD WOLF GMBH
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. NXTHERA, INC.
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. CONVERGENT LASER TECHNOLOGIES
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Financial Overview
14.10.4. Product Portfolio
14.10.5. SWOT Analysis
14.10.6. Key Developments

15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
15.3. RESEARCH METHODOLOGY
The List of Companies

1. Karl Storz Gmbh & Co.Kg
2. Olympus
3. Lumenis
4. Boston Scientific Corporation
5. NeoTract, Inc.
6. Coloplast Pty Ltd
7. Dornier MedTech.
8. Richard Wolf GmbH
9. NxThera, Inc.
10. Convergent Laser Technologies